Global Recombinant Human Somatropin Market Professional Survey Report 2016
- QYR596784
- 114 Pages
- June 2016
- Pharmaceuticals
Product types including
Injection
Freeze-dried powder
The segment applications including
Hospital use
Clinic use
Others
Segment regions including (the separated region report can also be offered)
North America
Europe
Japan
China
Southeast Asia
India
The players list (Partly, Players you are interested in can also be added)
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono
Ortho Biotech
Roche
MSD
Abcam
Kyowa Hakko Kirin
GenSci
Uni-Bio Science Group Limited
Livzon Pharmaceutical Group Inc.
Anhui Anke Biotechnology (Group) Co., Ltd.
LG Life Sciences,Ltd
Pfizer SA
With 16 top producers.
Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Recombinant Human Somatropin
1.1 Definition and Specifications of Recombinant Human Somatropin
1.1.1 Definition of Recombinant Human Somatropin
1.1.2 Specifications of Recombinant Human Somatropin
1.2 Classification of Recombinant Human Somatropin
1.2.1 Injection
1.2.2 Freeze-dried powder
1.3 Applications of Recombinant Human Somatropin
1.3.1 Hospital use
1.3.2 Clinic use
1.3.3 Others
1.4 Industry Chain Structure of Recombinant Human Somatropin
1.5 Industry Overview and Major Regions Status of Recombinant Human Somatropin
1.5.1 Industry Overview of Recombinant Human Somatropin
1.5.2 Global Major Regions Status of Recombinant Human Somatropin
1.6 Industry Policy Analysis of Recombinant Human Somatropin
1.7 Industry News Analysis of Recombinant Human Somatropin
2 Manufacturing Cost Structure Analysis of Recombinant Human Somatropin
2.1 Raw Material Suppliers and Price Analysis of Recombinant Human Somatropin
2.2 Equipment Suppliers and Price Analysis of Recombinant Human Somatropin
2.3 Labor Cost Analysis of Recombinant Human Somatropin
2.4 Other Costs Analysis of Recombinant Human Somatropin
2.5 Manufacturing Cost Structure Analysis of Recombinant Human Somatropin
2.6 Manufacturing Process Analysis of Recombinant Human Somatropin
3 Technical Data and Manufacturing Plants Analysis of Recombinant Human Somatropin
3.1 Capacity and Commercial Production Date of Global Recombinant Human Somatropin Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Recombinant Human Somatropin Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Recombinant Human Somatropin Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Recombinant Human Somatropin Major Manufacturers in 2015
4 Global Recombinant Human Somatropin Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Recombinant Human Somatropin Capacity and Growth Rate Analysis
4.2.2 2015 Recombinant Human Somatropin Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Recombinant Human Somatropin Sales and Growth Rate Analysis
4.3.2 2015 Recombinant Human Somatropin Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Recombinant Human Somatropin Sales Price
4.4.2 2015 Recombinant Human Somatropin Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Recombinant Human Somatropin Gross Margin
4.5.2 2015 Recombinant Human Somatropin Gross Margin Analysis (Company Segment)
5 Recombinant Human Somatropin Regional Market Analysis
5.1 North America Recombinant Human Somatropin Market Analysis
5.1.1 North America Recombinant Human Somatropin Market Overview
5.1.2 North America 2011-2016E Recombinant Human Somatropin Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Recombinant Human Somatropin Sales Price Analysis
5.1.4 North America 2015 Recombinant Human Somatropin Market Share Analysis
5.2 Europe Recombinant Human Somatropin Market Analysis
5.2.1 Europe Recombinant Human Somatropin Market Overview
5.2.2 Europe 2011-2016E Recombinant Human Somatropin Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Recombinant Human Somatropin Sales Price Analysis
5.2.4 Europe 2015 Recombinant Human Somatropin Market Share Analysis
5.3 Japan Recombinant Human Somatropin Market Analysis
5.3.1 Japan Recombinant Human Somatropin Market Overview
5.3.2 Japan 2011-2016E Recombinant Human Somatropin Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E Recombinant Human Somatropin Sales Price Analysis
5.3.4 Japan 2015 Recombinant Human Somatropin Market Share Analysis
5.4 China Recombinant Human Somatropin Market Analysis
5.4.1 China Recombinant Human Somatropin Market Overview
5.4.2 China 2011-2016E Recombinant Human Somatropin Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E Recombinant Human Somatropin Sales Price Analysis
5.4.4 China 2015 Recombinant Human Somatropin Market Share Analysis
5.5 Southeast Asia Recombinant Human Somatropin Market Analysis
5.5.1 Southeast Asia Recombinant Human Somatropin Market Overview
5.5.2 Southeast Asia 2011-2016E Recombinant Human Somatropin Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2011-2016E Recombinant Human Somatropin Sales Price Analysis
5.5.4 Southeast Asia 2015 Recombinant Human Somatropin Market Share Analysis
5.6 India Recombinant Human Somatropin Market Analysis
5.6.1 India Recombinant Human Somatropin Market Overview
5.6.2 India 2011-2016E Recombinant Human Somatropin Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Recombinant Human Somatropin Sales Price Analysis
5.6.4 India 2015 Recombinant Human Somatropin Market Share Analysis
6 Global 2011-2016E Recombinant Human Somatropin Segment Market Analysis (by Type)
6.1 Global 2011-2016E Recombinant Human Somatropin Sales by Type
6.2 Different Types Recombinant Human Somatropin Product Interview Price Analysis
6.3 Different Types Recombinant Human Somatropin Product Driving Factors Analysis
6.3.1 Injection Recombinant Human Somatropin Growth Driving Factor Analysis
6.3.2 Freeze-dried powder Recombinant Human Somatropin Growth Driving Factor Analysis
7 Global 2011-2016E Recombinant Human Somatropin Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use Recombinant Human Somatropin Growth Driving Factor Analysis
7.3.2 Clinic use Recombinant Human Somatropin Growth Driving Factor Analysis
7.3.3 Others Recombinant Human Somatropin Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Recombinant Human Somatropin
8.1 Novo Nordisk
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Novo Nordisk 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Novo Nordisk 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.2 Amgen
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Amgen 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Amgen 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.3 Sanofi
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Sanofi 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Sanofi 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.4 Eli Lilly
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Eli Lilly 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Eli Lilly 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.5 Merck Serono
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Merck Serono 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Merck Serono 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.6 Ortho Biotech
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Ortho Biotech 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Ortho Biotech 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.7 Roche
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Roche 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Roche 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.8 MSD
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 MSD 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 MSD 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.9 Abcam
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Abcam 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Abcam 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.10 Kyowa Hakko Kirin
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Kyowa Hakko Kirin 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Kyowa Hakko Kirin 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.11 GenSci
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 GenSci 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 GenSci 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.12 Uni-Bio Science Group Limited
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Uni-Bio Science Group Limited 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Uni-Bio Science Group Limited 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.13 Livzon Pharmaceutical Group Inc.
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Livzon Pharmaceutical Group Inc. 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Livzon Pharmaceutical Group Inc. 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.14 Anhui Anke Biotechnology (Group) Co., Ltd.
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Anhui Anke Biotechnology (Group) Co., Ltd. 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Anhui Anke Biotechnology (Group) Co., Ltd. 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.15 LG Life Sciences,Ltd
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 LG Life Sciences,Ltd 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 LG Life Sciences,Ltd 2015 Recombinant Human Somatropin Business Region Distribution Analysis
8.16 Pfizer SA
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Pfizer SA 2015 Recombinant Human Somatropin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Pfizer SA 2015 Recombinant Human Somatropin Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Recombinant Human Somatropin Consumption Forecast
9.2.2 Europe 2016-2021 Recombinant Human Somatropin Consumption Forecast
9.2.3 Japan 2016-2021 Recombinant Human Somatropin Consumption Forecast
9.2.4 China 2016-2021 Recombinant Human Somatropin Consumption Forecast
9.2.5 Southeast Asia 2016-2021 Recombinant Human Somatropin Consumption Forecast
9.2.6 India 2016-2021 Recombinant Human Somatropin Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Recombinant Human Somatropin Marketing Model Analysis
10.1 Recombinant Human Somatropin Regional Marketing Model Analysis
10.2 Recombinant Human Somatropin International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Recombinant Human Somatropin by Regions
10.4 Recombinant Human Somatropin Supply Chain Analysis
11 Consumers Analysis of Recombinant Human Somatropin
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Recombinant Human Somatropin
12.1 New Project SWOT Analysis of Recombinant Human Somatropin
12.2 New Project Investment Feasibility Analysis of Recombinant Human Somatropin
13 Conclusion of the Global Recombinant Human Somatropin Market Professional Survey Report 2016
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
